RFL insider trading
NYSE Real EstateRafael Holdings, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Rafael Holdings, Inc.
Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is Trappsol Cyclo, which is in phase 3 clinical trial being evaluated for the potential treatment of Niemann-Pick Disease Type C1 ("NPC1"), a rare, fatal and progressive genetic disorder; and CPI-613 (devimistat), a stable analog of normally transient, acylated catalytic intermediates of lipoate, which is in phase II of clinical trial. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1A and 1B clinical studies targeting patients with advanced cancers. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrument for Carpal Tunnel syndrome. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.
Company website: www.rafaelholdings.com
RFL insider activity at a glance
FilingIQ has scored 131 insider transactions for RFL since Mar 28, 2017. The most recent filing in our index is dated Mar 21, 2026.
Across the full history, 5 open-market purchases
and 6 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on RFL insider trades is 68.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest RFL Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Real Estate tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for RFL?
- FilingIQ tracks 131 Form 4 insider transactions for RFL (Rafael Holdings, Inc.), covering filings from Mar 28, 2017 onwards. 2 of those were filed in the last 90 days.
- Are RFL insiders net buyers or net sellers?
- Across the full Form 4 history for RFL, 5 transactions (4%) were open-market purchases and 6 (5%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does RFL insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is RFL in?
- Rafael Holdings, Inc. (RFL) is classified in the Real Estate sector, specifically Real Estate Services, with a current market capitalisation of $63.15M.
Methodology & sources
Every RFL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.